Clinical Trial Update: Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies [NA]

View source ↗

Summary

A hematopoietic stem cell transplant trial for high-risk hemoglobinopathies has been terminated; the conditions studied include sickle cell disease, transfusion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Neutropenia
• Diamond-blackfan Anemia
• Glanzmann Thrombasthenia
• Non-malignant Hematologic Disorders
• Paroxysmal Nocturnal Hemoglobinuria
• Shwachman-diamond Syndrome
• Sickle Cell Disease
• Transfusion-dependent Thalassemia

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Sickle Cell Disease, Transfusion Dependent Alpha- or Beta- Thalassemia | NA | Status: TERMINATED